scispace - formally typeset
G

Giulio Maria Pasinetti

Researcher at Icahn School of Medicine at Mount Sinai

Publications -  348
Citations -  23545

Giulio Maria Pasinetti is an academic researcher from Icahn School of Medicine at Mount Sinai. The author has contributed to research in topics: Alzheimer's disease & Hippocampal formation. The author has an hindex of 75, co-authored 331 publications receiving 21345 citations. Previous affiliations of Giulio Maria Pasinetti include University of Brescia & Mount Sinai Health System.

Papers
More filters
Journal ArticleDOI

Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer’s disease

TL;DR: It is found that diet‐induced insulin resistance promoted amyloidogenic β‐amyloid (Aβ) A β1–40 and Aβ1–42 peptide generation in the brain that corresponded with increased γ‐secretase activities and decreased insulin degrading enzyme (IDE) activities.
Journal ArticleDOI

Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer's disease brain

TL;DR: It was found that synthetic beta-amyloid peptides induced cyclooxygenase-2 expression in SH-SY5Y neuroblastoma cells in vitro, suggesting a mechanism for cyclo oxygengen enzyme-2 up-regulation in Alzheimer's disease.
Journal ArticleDOI

Grape-derived polyphenolics prevent Abeta oligomerization and attenuate cognitive deterioration in a mouse model of Alzheimer's disease.

TL;DR: It is found that a naturally derived grape seed polyphenolic extract can significantly inhibit amyloid β-protein aggregation into high-molecular-weight oligomers in vitro and suggests that grape seed-derived polyphenolics may be useful agents to prevent or treat AD.